Geode Capital Management’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,050,879
| Closed | -$268K | – | 4861 |
|
|
2023
Q1 | $268K | Buy |
1,050,879
+1,934
| +0.2% | +$493 | ﹤0.01% | 3910 |
|
|
2022
Q4 | $1.24M | Buy |
1,048,945
+13,513
| +1% | +$15.9K | ﹤0.01% | 3256 |
|
|
2022
Q3 | $2.11M | Buy |
1,035,432
+688,154
| +198% | +$1.4M | ﹤0.01% | 3066 |
|
|
2022
Q2 | $534K | Buy |
347,278
+62,715
| +22% | +$96.4K | ﹤0.01% | 3725 |
|
|
2022
Q1 | $1.44M | Buy |
284,563
+226,510
| +390% | +$1.14M | ﹤0.01% | 3431 |
|
|
2021
Q4 | $359K | Buy |
+58,053
| New | +$359K | ﹤0.01% | 4212 |
|